Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology
(Sprache: Englisch)
This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
54.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology “
Klappentext zu „Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology “
This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies).Bibliographische Angaben
- Autoren: Witold Lasek , Radoslaw Zagozdzon
- 2016, 1st ed. 2016, VII, 75 Seiten, Maße: 16,1 x 23,7 cm, Kartoniert (TB), Englisch
- Verlag: Springer, Berlin
- ISBN-10: 3319469053
- ISBN-13: 9783319469058
- Erscheinungsdatum: 06.10.2016
Sprache:
Englisch
Kommentar zu "Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology"
Schreiben Sie einen Kommentar zu "Interleukin 12: Antitumor Activity and Immunotherapeutic Potential in Oncology".
Kommentar verfassen